University of Texas/Texas AM Investment Management Co (UTIMCO)’s BioMarin Pharmaceuticals BMRN Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.89M	Buy	+33,065	New	+$1.81M	0.22%	67
2026 Q1	–	Sell	-41,928	Closed	-$2.49M	–	311
2025 Q4	$2.49M	Buy	+41,928	New	+$2.28M	0.35%	54
2024 Q4	–	Sell	-10,213	Closed	-$718K	–	176
2024 Q3	$718K	Buy	10,213 +1,080	+12%	+$90.3K	0.12%	73
2024 Q2	$752K	Sell	9,133 -5,567	-38%	-$463K	0.15%	73
2024 Q1	$1.28M	Buy	+14,700	New	+$1.32M	0.27%	57

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s BMRN Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 33,065 shares worth $1.89M. The stake represents 0.22% of the portfolio and ranks #67 among its holdings. This is a return to the name: University of Texas/Texas AM Investment Management Co (UTIMCO) previously reported a position in BMRN as recently as Q4 2025.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BMRN in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.49M in Q4 2025. 355 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

University of Texas/Texas AM Investment Management Co (UTIMCO) held 33,065 shares of BioMarin Pharmaceuticals worth $1.89M as of Q2 2026.
BioMarin Pharmaceuticals was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
BioMarin Pharmaceuticals made up 0.22% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #67 holding.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BioMarin Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
University of Texas/Texas AM Investment Management Co (UTIMCO)'s BioMarin Pharmaceuticals position peaked at $2.49M in Q4 2025.
355 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.